Molecular biology studies in Philadelphia chromosome-negative chronic myeloid leukemia

High-dose chemotherapy with autologous stem cell transplants in adult primary non-seminoma mediastinal germ-cell tumors. A report from the Cellular Therapy and Immunobiology working party of the EBMT.

ESMO open·2024

Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study.

Frontiers in pharmacology·2023

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.

Leukemia·2020

Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors.

Journal of experimental & clinical cancer research : CR·2019

Salvage high-dose chemotherapy in female patients with relapsed/refractory germ-cell tumors: a retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT).

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Treatment and outcome of 2904 CML patients from the EUTOS population-based registry.

Leukemia·2016

First line asciminib in chronic myeloid leukemia: a quest for the "Holy Grail" of tolerability.

Haematologica·2026

Excess mortality convergence after paediatric allogeneic transplantation: a caveat for the right to be forgotten. Comment on: "Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemia".

Haematologica·2026

Successful treatment of systemic juvenile xanthogranuloma with an ABL2::GAB2 fusion using dasatinib after failure of conventional chemotherapy and MEK inhibition.

Haematologica·2026

Outcomes of CHOP versus CHOEP/EPOCH in aggressive adult T-cell leukemia/lymphoma: an international cohort analysis.

Haematologica·2026

Central nervous system management remains an evidence gap in first-line tagraxofusp therapy for blastic plasmacytoid dendritic cell neoplasm. Comment on: "First-line tagraxofusp leads to durable responses and prolonged survival in adults with blastic plasmacytoid dendritic cell neoplasm regardless of fitness level".

Haematologica·2026

Germline lymphoma-predisposing variants: impact on age of cancer diagnosis and survival in pediatric patients.

Haematologica·2026

Switching apo- and holo-IscR control of LcrF alters how iron and oxygen regulate Yersinia virulence factors.

Infection and immunity·2026

Time- and Temperature-Dependent Response of Acquired FV Inhibitors: Implications for Laboratory Diagnosis and Clinical Management.

Journal of clinical laboratory analysis·2026

Photocatalytic Construction of Multivalent Peptide-Human Serum Albumin (HSA) Conjugates Capable of Effectively Attenuating Phagocytosis.

ACS applied materials & interfaces·2026

Indole hybrids as promising anti-hepatocellular carcinoma agents: a comprehensive review of recent advances and therapeutic prospects.

Future medicinal chemistry·2026

The Diagnostic Mirage: Xanthogranulomatous Cholecystitis and the Illusion of Gallbladder Carcinoma.

Cureus·2026

The machine-learning classifier ALLCatchR2 identifies 20 T-ALL subtypes across cohorts and age groups.

HemaSphere·2026

Related Experiment Videos

Molecular biology studies in Philadelphia chromosome-negative chronic myeloid leukemia

Related Concept Videos

High-dose chemotherapy with autologous stem cell transplants in adult primary non-seminoma mediastinal germ-cell tumors. A report from the Cellular Therapy and Immunobiology working party of the EBMT.

Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study.

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.

Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors.

Salvage high-dose chemotherapy in female patients with relapsed/refractory germ-cell tumors: a retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT).

Treatment and outcome of 2904 CML patients from the EUTOS population-based registry.

First line asciminib in chronic myeloid leukemia: a quest for the "Holy Grail" of tolerability.

Excess mortality convergence after paediatric allogeneic transplantation: a caveat for the right to be forgotten. Comment on: "Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemia".

Successful treatment of systemic juvenile xanthogranuloma with an ABL2::GAB2 fusion using dasatinib after failure of conventional chemotherapy and MEK inhibition.

Outcomes of CHOP versus CHOEP/EPOCH in aggressive adult T-cell leukemia/lymphoma: an international cohort analysis.

Germline lymphoma-predisposing variants: impact on age of cancer diagnosis and survival in pediatric patients.

Switching apo- and holo-IscR control of LcrF alters how iron and oxygen regulate Yersinia virulence factors.

Time- and Temperature-Dependent Response of Acquired FV Inhibitors: Implications for Laboratory Diagnosis and Clinical Management.

Photocatalytic Construction of Multivalent Peptide-Human Serum Albumin (HSA) Conjugates Capable of Effectively Attenuating Phagocytosis.

Indole hybrids as promising anti-hepatocellular carcinoma agents: a comprehensive review of recent advances and therapeutic prospects.

The Diagnostic Mirage: Xanthogranulomatous Cholecystitis and the Illusion of Gallbladder Carcinoma.

The machine-learning classifier ALLCatchR2 identifies 20 T-ALL subtypes across cohorts and age groups.

Related Experiment Videos

Molecular biology studies in Philadelphia chromosome-negative chronic myeloid leukemia

Related Concept Videos

Related Articles